An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
Stopped Recruitment/enrollment ended early due to the COVID-19 pandemic
Conditions
- Attention Deficit Hyperactivity Disorder
Interventions
- DRUG: Guanfacine
- DRUG: Lisdexamfetamine
Sponsor
New York State Psychiatric Institute
Collaborators
- [object Object]
- [object Object]
- [object Object]